Enlyte Pharmacy Experts Speak on Turning Challenges Into Opportunities
June 24, 2024
Clients face numerous challenges in managing their workers' compensation pharmacy programs including capturing all pharmacy utilization and costs as well as addressing abuse by price opportunists. In this Enlytening Conversation we’ll dig deeper into these issues and others to find proactive opportunities to address pharmacy challenges through identification, regulation, and continually reevaluating outcomes and analytics to better understand how the right pharmacy partner can positively impact overall spend and claims outcomes.
Enlyte Experts Discuss the Benefit of a Holistic Approach to Pharmacy
June 24, 2024
Seizing opportunity within the complexities of workers’ comp prescription utilization requires a holistic approach that manages all transactions to gain the full picture of medications being utilized. This Enlytening Conversation covers key factors for payers to consider that impact pharmacy utilization and cost, including legislative and regulatory challenges, physician dispensing, utilization controls, complex billing issues and cost management solutions that consider therapy as a whole.
Strategies for Combating Mental Health Challenges in Injured Employees
April 23, 2024
A Guide for Carriers and Employers Are your employees struggling with mental health challenges?
Ask The Pharmacist: Topical vs. Systemic Pain Medication
April 1, 2024
Managing chronic pain with medications can be difficult for various reasons. Pain experiences and treatment effectiveness may differ among individuals and caregivers.
Ask The Pharmacist: The Role of a Pharmacy and Therapeutics (P&T) Committee
March 1, 2024
A Pharmacy and Therapeutics (P&T) committee plays a crucial role in the realm of health care, particularly in the context of a workers’ compensation pharmacy benefit manager (PBM). This committee is comprised of health care professionals, such as physicians and pharmacists, who are responsible for evaluating and making decisions about the formulary—a continually updated list of medications covered by a prescription drug plan.
Closing Loopholes: Tackling Drug Price Inflation in Work Comp
February 22, 2024
Ask The Pharmacist: Risk Assessment for Opioid Use Disorder (OUD)
February 6, 2024
On December 19, 2023, the U.S. Food and Drug Administration (FDA) approved the first test (AvertD) that uses DNA in assessing whether certain individuals may have an elevated risk of developing opioid use disorder (OUD).